Shareholder says Innophos should consider sale
FrontFour Capital Group LLC, which holds a 3.3 percent stake in specialty phosphate maker Innophos Holdings Inc., sent a letter to Innophos dated Oct. 7, suggesting that the company consider a sale. Other alternatives included pursuing options to reducing its GTSP exposure, improving financial disclosures regarding capital spending, implementing a more attractive dividend, and accelerating share repurchase activity.
Innophos confirmed receipt of the letter and said it regularly engages in open and transparent dialogue with investors and will always consider constructive input from shareholders that helps drive long-term shareholder value. Frontfour had met with Innophos executives Aug. 14. Frontfour is concerned about what it calls a significant valuation gap between Innophos’ current share price versus comparable publicly traded specialty chemical companies with sizable exposure to the food, beverage and pharmaceutical end markets.